Inflammation occurring in many neurodegenerative diseases, such as multiple sclerosis and Alzheimer's disease, leads to changes in the cellular environment that will favor the activation of oligodendrocyte TRPA1. This evidence concerns the gene TRPA1 and Alzheimer disease.